BioSpace News Archive

BioMidwest

New Analysis Published in Peer-reviewed Psychiatry Research Shows Advantages of Combinatorial Algorithm of GeneSight® Psychotropic Test

Myriad Genetics, Inc., a leader in genetic testing and precision medicine, announced the peer-reviewed journal Psychiatry Research has published a new analysis of GeneSight® Psychotropic, the company’s mental health medication test, in its Feb. 2022 edition.

February 23, 2022

·

5 min read

Business

Quanterix Corporation to Release Fourth Quarter and Full Year 2021 Financial Results on March 1, 2022

Quanterix Corporation today announced that it will release its financial results for fourth quarter 2021 before the start of trading on Tuesday, March 1, 2022.

February 23, 2022

·

2 min read

BioMidwest

MitoChem Therapeutics to Present at Mitochondria-Targeted Drug Development Summit

MitoChem Therapeutics, Inc., a privately held company developing therapies for diseases involving mitochondrial dysfunction, announced that Bärbel Rohrer Ph.D., CSO, will present at the Mitochondrial-Targeted Drug Development Summit on Thursday, February 24, 2022 at 11:30am ET.

February 23, 2022

·

2 min read

Plasma Therapy Market Insights: To Gain Popularity in Treatment of Viral Infections, Skin Diseases, and Orthopedic Condition

Plasma therapy or convalescent plasma therapy is one of the most popular and constructive methods to boost the immune system.

February 23, 2022

·

3 min read

Veterinary Artificial Reproduction Market: Veterinary Artificial Reproduction to Gain Popularity to Maintain Health of Livestock

Pets are now treated as a family member. People opt for pet insurance and proper health care plan and maintain their diet.

February 23, 2022

·

3 min read

Business

Gemina Labs Establishes UK Subsidiary And Appoints David Browning As Head Of Productization

Gemina Laboratories Ltd. is pleased to announce the formation of a wholly owned UK Subsidiary, Gemina Laboratories Limited, and the appointment of David Browning as Head of Productization.

February 23, 2022

·

6 min read

Alessa Therapeutics Announces First Patient Enrollment in Biolen®+RT Study in Collaboration with the National Cancer Institute

The study will evaluate the feasibility of replacing systemic androgen deprivation therapy (ADT) with targeted local delivery of an anti-androgen agent in patients in whom ADT plus radiation therapy is indicated for the treatment of localized prostate cancer.

February 23, 2022

·

2 min read

Business

Adocia announces 2021 fourth quarter financial results

Adocia, a clinical-stage biopharmaceutical company specialized in the development of innovative formulations of proteins and peptides for the treatment of diabetes and other metabolic diseases announced its fourth quarter financial results.

February 23, 2022

·

4 min read

Business

OraSure Technologies Reports 4Q21 Revenue of $63.6 Million; InteliSwab® Production Scales Up

OraSure Technologies, Inc., a leader in point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, announced its financial results for the three months ended December 31, 2021 and fiscal year 2021.

February 23, 2022

·

19 min read

Business

Maravai LifeSciences Reports Fourth Quarter and Full Year 2021 Financial Results and Updates 2022 Financial Guidance

Maravai LifeSciences Holdings, Inc., a global provider of life science reagents and services to researchers and biotech innovators, reported financial results for the fourth quarter and the full year ended December 31, 2021, together with other business updates.

February 23, 2022

·

17 min read